Microarrays & Multiplexing
News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.
Immunovia Cleared to Offer Pancreatic Cancer Test in Rhode Island
The test is designed to detect nine serum biomarkers of pancreatic ductal adenocarcinoma, including the protein CA19-9.
Prostate Cancer Analysis Explores Age-Related Risk Linked to Polygenic Risk Score
While the relative risk associated with a prostate cancer PRS decreased with age, case-control data suggested absolute risk remained fairly stable over time.
The test is already available commercially in Spain, and the company intends to next launch its offering in Italy, as it expands to other European markets.
The 32-gene signature showed potential in predicting South Korean gastric cancer patients' overall survival and response to chemotherapy and immunotherapy.